Theravance Biopharma (TBPH) Cost of Revenue (2014 - 2018)
Theravance Biopharma's Cost of Revenue came in at $632,000 for Q4 2018, down 72.5% from $2.3 million a year earlier and down 10.4% from the prior quarter.
Powered by 
Analysis
Theravance Biopharma (TBPH) Cost of Revenue (2014 - 2018) Analysis & Trends
For FY2018, Theravance Biopharma's Cost of Revenue was $715,000, down 88.1% from FY2017.
- Cost of Revenue carries a four-year compound annual growth rate of -35.2% (FY2014 to FY2018).
- Going back by year, Cost of Revenue was $6.03 million in FY2017 (+108.4%), $2.89 million in FY2016 (-37.9%), $4.66 million in FY2015 (+14.8%) and $4.06 million in FY2014.
- The Q4 2018 figure represents the lowest quarterly Cost of Revenue since Q1 2017.
- Year-over-year, Cost of Revenue increased in five of the last eight quarters, with growth averaging 41.9%.
- The fastest year-over-year change in Cost of Revenue over five years came in Q3 2017 (growth of 196.7%), and the weakest in Q4 2018 (a decline of 72.5%).
- Business Quant data shows TBPH's Cost of Revenue at $705,000 (Q3 2018), $1.45 million (Q2 2018) and $826,000 (Q1 2018) in the three quarters before Q4 2018.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cost of Rev (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 3.27 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 8.05 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 4.29 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 4.40 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 3.71 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 2.52 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 2.81 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | 1.58 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 4.09 Bn |
| 10 | Theravance Biopharma | 883.70 Mn | -543.66 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2018 | 632,000.00 |
| Sep 30, 2018 | 705,000.00 |
| Jun 30, 2018 | 1.45 Mn |
| Mar 31, 2018 | 826,000.00 |
| Dec 31, 2017 | 2.30 Mn |
| Sep 30, 2017 | 985,000.00 |
| Jun 30, 2017 | 1.36 Mn |
| Mar 31, 2017 | 565,000.00 |
| Dec 31, 2016 | 1.15 Mn |
| Sep 30, 2016 | 332,000.00 |
| Jun 30, 2016 | 638,000.00 |
| Mar 31, 2016 | 778,000.00 |
| Dec 31, 2015 | 3.20 Mn |
| Sep 30, 2015 | 581,000.00 |
| Jun 30, 2015 | 505,000.00 |
| Mar 31, 2015 | 371,000.00 |
| Dec 31, 2014 | 3.22 Mn |
| Sep 30, 2014 | 369,000.00 |
| Jun 30, 2014 | 279,000.00 |
| Mar 31, 2014 | 188,000.00 |
API Access
Theravance Biopharma Cost of Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cost-of-revenue&ticker=TBPH&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cost-of-revenue", "ticker": "TBPH", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cost-of-revenue&ticker=TBPH&period=max&api_key=YOUR_API_KEY");
const data = await res.json();